To investigate whether the differential BAX localization has a potential impact on biological traits of tumors, we integrated our results with two independent cohorts of authentic HCC patients and assessed clinical outcomes by sub-clustering the tumors based on BAX-protected gene expression signatures from non-tumor and tumor tissues. This evidence concerns the gene BAX and neoplasm.